openPR Logo
Press release

What's driving the Dermatitis Drugs Market Growth? Prominent Players: Valeant Pharmaceuticals, Astellas Pharma US, Pfizer, Mylan, Bayer, Allergan, LEO Pharma, Regeneron Pharmaceuticals, Inc, Anacor Pharmaceuticals

07-03-2019 01:43 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt Ltd

What's driving the Dermatitis Drugs Market Growth? Prominent

The Global Dermatitis Drugs Market will expand considerably in the coming years driven by the advancements across numerous drug classes. According to a report published by Fortune Business Insights, titled “Dermatitis Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 6,097.4 Mn in 2018. Fortune Business Insights predicts that the market will rise impressively at a CAGR of 10.2% and reach US$ 13,630.8 Mn by the end of 2026.

Get Exclusive Sample PDF by Fortune Business Insights:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatitis-drugs-market-100658

Major Leading Players Mentioned:
• Valeant Pharmaceuticals
• Astellas Pharma US
• Pfizer
• Mylan
• Bayer
• Allergan
• LEO Pharma
• Regeneron Pharmaceuticals, Inc.
• Anacor Pharmaceuticals

The severity of dermatitis has led to an increasing need for efficient drugs. This, in turn, has led to a growing emphasis on the research and development of newer drugs that can be used in compliance with the regulations, enforced by related authorities. Increasing usage approvals will open up numerous windows for the growth of the global market. The report provides an in-depth analysis of various companies that have made significant contributions to the growth of the global dermatitis drugs market.

Topical Treatment for Atopic Dermatitis gets FDA Nod, Subsequently Aiding the Market’s Expansion
The global dermatitis drugs market will derive significant growth from increasing usage approvals. In 2017, the Food and Drug Administration passed approval for a new topical treatment for atopic dermatitis. The topical treatment ‘Eucrisa’ was aimed at the treatment of children and adults with mild to moderate atopic dermatitis. The use of Eucrisa to minimize the effects of dermatitis has fueled the demand for the products, across the world.

The ability of Eucrisa to act on a body enzyme ‘PDE4’ has created several benefits of the product and this, in turn, will lead to an increase in adoption. After successful clinical trials, Eucrisa was seen to reduce skin rashes, itching, and lichenification. The applications of Eucrisa in the healthcare industry have had a positive impact on the Global Dermatitis Drugs Market and will favor the growth of the market in the coming years. Fortune Business Insights has predicted that growing usage approvals will bode well for the market in the near future.

Increasing Mergers and Acquisitions Will Enable Growth

The global atopic dermatitis market will witness growth opportunities due to contributions from leading companies and their exceptional business strategies. Recent trends in dermatitis treatment include company mergers and acquisitions, aimed at the betterment of prevailing drugs and creating new drugs. The growing mergers and acquisitions have boded well for the market and Fortune Business Insights has predicted that these activities will induce significant growth in the global dermatitis market in the coming years.

In 2016, Pfizer announced that it plans to acquire Anacor Pharmaceuticals for an estimated US$ 5.2 Bn. The company has splashed a huge amount for the take-over of Anacor and this is a strong indication of future growth. The report includes mergers and acquisition similar to the Pfizer-Anacor deal and gauges the impact of such M&As on the global dermatitis drugs market.

Major Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of major dermatitis types by key countries, 2018
4.2. Recent industry developments such as mergers & acquisitions
4.3. Pipeline analysis
4.4. Patent landscape
4.5. Reimbursement scenario by key countries
4.6. Regulatory scenario for key countries
TOC Continued…!

Browse Complete Report
https://www.fortunebusinessinsights.com/industry-reports/dermatitis-drugs-market-100658

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Dermatitis Drugs Market Growth? Prominent Players: Valeant Pharmaceuticals, Astellas Pharma US, Pfizer, Mylan, Bayer, Allergan, LEO Pharma, Regeneron Pharmaceuticals, Inc, Anacor Pharmaceuticals here

News-ID: 1795290 • Views:

More Releases from Fortune Business Insights Pvt Ltd

Commercial Drone Market Size, Share, Industry Development, Growth & Trends by 2030
Commercial Drone Market Size, Share, Industry Development, Growth & Trends by 20 …
The global commercial drone market size was valued at USD 8.77 billion in 2022. The market is projected to grow from USD 10.98 billion in 2023 to USD 54.81 billion by 2030, exhibiting a CAGR of 25.82% during the forecast period. A drone, also known as an unmanned aerial vehicle, is a flying device, equipped with a camera and sensor. Different industries are investing in drone technology and trying to
Aircraft Engine Market Latest Key Drivers and Future Demand Forecast by 2029
Aircraft Engine Market Latest Key Drivers and Future Demand Forecast by 2029
According to a recent report by Fortune Business Insights, the global Aircraft Engine Market is expected to reach a size of USD 112.61 billion by 2028, growing at a CAGR of 10.87% during the forecast period 2021-2028. The report offers a thorough analysis of the market size, regional landscape, revenue forecasts, and upcoming challenges in the market. It also provides current statistics and future predictions, aiming to evaluate growth prospects,
Space Mining Market the Development Strategies Adopted by Major Key Players And …
The increasing investments by mining companies is expected to foster healthy growth of the market during the forecast period, sates Fortune Business Insights in a report, titled "Space Mining Market Size, Share & Industry Analysis, By Phase (Spacecraft Design, Launch, Operation), By Asteroid type (Type C, Type S, Type M, Others), By Application (Construction, Resource Harvesting, 3D Printing, Others) and Regional Forecast, 2023-2030." The growing number of government initiatives for
Radar Level Transmitter Market Size, Gross Margin, Trends, Future Demand, Analys …
The higher level of accuracy, reliability, and stability offered by radar level transmitters is expected to fuel the demand of the market during the forecast period, states Fortune Business Insights, in a report, titled "Radar Level Transmitter Market Size, Share & Industry Analysis, By Technology (Contact, Noncontact), By Frequency Range (C and X Band, W Band, K Band), By Application (Liquids, slurries, and interfaces, Solids), By Industry (Oil & Gas,

All 5 Releases


More Releases for Dermatitis

Dermatitis Market Growth Fueled By Increasing Disease Prevalence And Food Allerg …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Dermatitis Market Size Growth Forecast: What to Expect by 2025? Over the past few years, the size of the dermatitis market has expanded significantly. It is predicted to rise from $6.77 billion in 2024 to $7.13 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.4%. The
Major Growth Driver Identified in 2025 Seborrheic Dermatitis Market: Rising Prev …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Seborrheic Dermatitis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for seborrheic dermatitis has experienced rapid expansion lately. It's projected to swell from $2.76 billion in 2024 to $3.08 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.8%. The
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Atopic Dermatitis Market Size By 2025? The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Atopic Dermatitis Pipeline
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029. Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger